LIPPOLDT DARIN (Chief Legal Officer) sold 9.2% of their position (4.38K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $698.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/10/2025ACC: 0001504783-25-000006
Officer· Chief Legal Officer
Since Feb 2019
-4.38K
Net shares
Net seller
$698.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.38K acquired · 8.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.38K
Price / share
$43.24
Trade value
$189.22K
% of position
10.1%
12/8/2025
43.41K→47.78K
Common Stock
Direct
Shares
−4.38K
Price / share
$159.65
Trade value
$698.62K
% of position
9.2%
12/8/2025
47.78K→43.41K
Total
Net shares
+0.00
Net value
-$509.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/8/2025 | M · Option Exercise | +4.38K | $43.24 | $189.22K | 10.1% | 43.41K | 47.78K |
| Common Stock Direct | 12/8/2025 | S · Sale | −4.38K | $159.65 | $698.62K | 9.2% | 47.78K | 43.41K |
| Total | +0.00 | -$509.40K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
4.38K shares
Shares
−4.38K
Strike price
43.24
Held after
0.00
Exercisable
—
12/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock4.38K shares | 12/8/2025 | M · Option Exercise | −4.38K | 43.24 | — | 0.00 |